DTRA is working hard to protect American warfighters and their allies from threats posed by chemical and biological weapons. They provide a wide spectrum of support to the military services, combatant commands and international partners, from innovating new technologies to detect chemical and biological threats, to developing new capabilities to protect them through programs such as the Transformational Medical Technologies Initiative.
Not only do chemical and biological threats imperil our nation’s warfighters and our allies; they are a danger to innocent civilians in the homeland and throughout the world. Defending the country against chemical and biological threats presents a wide variety of challenges. DTRA works to tackle these challenges by partnering with interagency organizations such as the Department of Health and Human Services, to prepare for biological and chemical events. In cooperation with DoD and HHS, DTRA is using state-of-the-art technology and executing our first agent-based, high performance computational analysis system, which has resulted in a revolutionary pandemic influenza modeling capability. DTRA recently completed part of a significant study that looked at a nine region response effort with multiple interventions. The result of this study will help the U.S. prepare for a possible pandemic, and is a perfect example of DTRA’s Reachback capabilities, technical expertise and the value DTRA provides to other departments and agencies.